Oscotec Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oscotec Incorporation with three other
companies in this sector in KOREA (SOUTH) :
Anterogen Co Ltd
sales of 4.15 billion Korean Won [US$3.53 million]
of which 78%
Cube&Company Co Ltd
(7.38 billion Korean Won [US$6.28 million]
of which 98%
was Synthesis), and
(4.25 billion Korean Won [US$3.61 million]
of which 86%
was Wholesale of Medicine and Medical Suppli).
Sales fell dramatically in 2019:
During the year ended December of 2019, sales at
Oscotec Incorporation were 4.37 billion Korean Won (US$3.72 million).
decrease of 76.6%
versus 2018, when the company's sales were 18.70 billion Korean Won .
Contributing to the drop in overall sales was the 96.2% decline
in Other Segment, from 14.66 billion Korean Won to 558.89 million Korean Won .
There were also decreases in sales in
Food Segment (down 42.9% to 901.06 million Korean Won )
However, these declines were partially offset by the increase in sales of
Medical Segment (up 18.0% to 2.91 billion Korean Won )